학술논문
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease
Document Type
Article
Author
Source
In: Journal of Hematology and Oncology . (Journal of Hematology and Oncology, December 2023, 16(1))
Subject
Language
English
ISSN
17568722